FrancophonIA/ELRC3.0 huggingface dataset:
English: 100 mg twice daily (25 mg, 100 mg capsules or 20 mg/mL oral solution)
Danish: 100 mg to gange dagligt (25 mg, 100 mg kapsler eller 20 mg/ml oral opløsning)
English: VITRAKVI 100 mg hard capsules
Danish: VITRAKVI 100 mg hårde kapsler
English: SD, NE NA
Danish: SD; NE Ikke relevant
English: VITRAKVI 25 mg hard capsules
Danish: VITRAKVI 25 mg hårde kapsler
English: Myalgia Muscular weakness
Danish: Myalgi Muskelsvaghed
English: VITRAKVI 100 mg hard capsules Each hard capsule contains larotrectinib sulfate equivalent to 100 mg of larotrectinib.
Danish: VITRAKVI 100 mg hårde kapsler Hver hård kapsel indeholder larotrectinibsulfat, svarende til 100 mg larotrectinib.
English: Doses up to 100 mg/m2 twice daily (25 mg, 100 mg capsules or 20 mg/mL oral solution)
Danish: Doser på op til 100 mg/m2 to gange dagligt (25 mg, 100 mg kapsler eller 20 mg/ml oral opløsning)
English: Median time on treatment was 12.1 months (range: 0.66 to 40.7 months) based on July 2018 cut-off. Fifty-two percent of patients had received VITRAKVI for 12 months or more and 30% had received VITRAKVI 18 months or more, with follow-up ongoing at the time of the analysis.
Danish: Den mediane behandlingstid var 12,1 måneder (interval: 0,66 til 40,7 måneder), baseret på tilgængelige data med skæringsdato juli 2018.
English: Clinical data in healthy adult subjects indicate that co-administration of a single 100 mg VITRAKVI dose with rifampin (a strong CYP3A and P-gp inducer) 600 mg twice daily for 11 days decreased larotrectinib Cmax and AUC by 71% and 81%, respectively.
Danish: Kliniske data fra raske, voksne personer indikerer, at samtidig administration af en enkelt 100 mg VITRAKVI-dosis med rifampin (en potent CYP3A- og P-gp-induktor) 600 mg to gange dagligt i 11 dage reducerede larotrectinib Cmax og AUC med hhv. 71 % og 81 %.
English: VITRAKVI 25 mg hard capsules Each hard capsule contains larotrectinib sulfate equivalent to 25 mg of larotrectinib.
Danish: VITRAKVI 25 mg hårde kapsler Hver hård kapsel indeholder larotrectinibsulfat, svarende til 25 mg larotrectinib.
English: Nausea Constipation Vomiting
Danish: Kvalme Forstoppelse Opkastning
English: Biliary (n=2) SCLC (n=1)b, d Appendix (n=1) Breast (n=1)
Danish: (n = 2) SCLC (n = 1)b,d
English: At the recommended dose, the Cmax in paediatric patients (≥3 months to <12 years of age) was higher than in adults, but the AUC was similar to that in adults.
Danish: Ved den anbefalede dosis var Cmax hos pædiatriske patienter (≥ 3 måneder til < 12 år)
English: Males of reproductive potential with a non-pregnant woman partner of child bearing potential should be advised to use highly effective contraception during treatment with VITRAKVI and for at least one month after the final dose (see section 4.6).
Danish: Mænd med reproduktionspotentiale med en kvindelig partner i den fertile alder, som ikke er gravid, skal rådes til at bruge meget sikker kontraception under behandlingen med VITRAKVI og i mindst en måned efter den sidste dosis (se pkt.
English: saquinavir, rifabutin, efavirenz - a medicine used to treat depression called nefazodone - medicines used to treat epilepsy called phenytoin, carbamazepine, phenobarbital - a herbal medicine used to treat depression called St. John's wort - a medicine used to treat tuberculosis called rifampicin - a medicine used for strong pain relief called alfentanil - medicines used to prevent organ rejection after an organ transplant called ciclosporin, sirolimus,
Danish: phenobarbital - et naturlægemiddel, der anvendes til at behandle depression, kaldet perikon - et lægemiddel, der anvendes til at behandle tuberkulose, kaldet rifampicin - et lægemiddel, der anvendes til stærk smertelindring, kaldet alfentanil - lægemidler, der anvendes til at forhindre organafstødning efter en organtransplantation, kaldet ciclosporin, sirolimus, tacrolimus - et lægemiddel, der anvendes til at behandle unormal hjerterytme, kaldet quinidin - lægemidler, der anvendes til at behandle migræne, kaldet dihydroergotamin, ergotamin - et lægemiddel, der anvendes til at behandle langvarige smerter, kaldet fentanyl - et lægemiddel, der anvendes til at kontrollere ufrivillige bevægelser eller lyde, kaldet pimozid.
English: Grade 4 was the highest reported grade for adverse reactions neutrophil count decreased (1.6%) and ALT increased (< 1%).
Danish: For bivirkningerne med reduktion af neutrofiltallet (1,6 %) og forhøjet ALAT (< 1 %) var grad 4 den højeste rapporterede.
English: Clinical data in healthy adult subjects indicate that co-administration of a single 100 mg VITRAKVI dose with itraconazole (a strong CYP3A inhibitor and P-gp and BCRP inhibitor) 200 mg once daily for 7 days increased larotrectinib Cmax and AUC by 2.8-fold and 4.3-fold, respectively.
Danish: Kliniske data fra raske, voksne personer indikerer, at samtidig administration af en enkelt 100 mg VITRAKVI-dosis med itraconazol (en potent CYP3A-inhibitor og P-gp og BCRP-inhibitor) 200 mg en gang dagligt i 7 dage forhøjede larotrectinib Cmax og AUC hhv. 2,8 gange og 4,3 gange.
English: In vitro studies show that in liquid volumes relevant to the gastrointestinal (GI) tract larotrectinib is fully soluble over entire pH range of the GI tract.
Danish: In vitro-studier viser, at larotrectinib er helt opløseligt i hele pH-intervallet i mave-tarm-kanalen i de væskevoluminer, der er relevante for mave-tarmkanalen.
English: 75 mg twice daily
Danish: 75 mg 2 gange dagligt
English: Resume at the next dose modification if resolution occurs within 4 weeks.
Danish: Hvis bivirkningen er væk inden for 4 uger, genoptag behandlingen ved den næste dosismodifikation.
English: Each capsule contains larotrectinib sulfate, equivalent to 100 mg of larotrectinib.
Danish: Hver kapsel indeholder larotrectinibsulfat svarende til 100 mg larotrectinib.
English: Each capsule contains larotrectinib sulfate, equivalent to 25 mg of larotrectinib.
Danish: Hver kapsel indeholder larotrectinibsulfat svarende til 25 mg larotrectinib.
English: Women of childbearing potential must use highly effective contraception while taking VITRAKVI and for at least one month after stopping treatment (see sections 4.5 and 4.6).
Danish: Kvinder i den fertile alder skal bruge meget sikker kontraception under behandlingen med VITRAKVI og i mindst en måned efter behandlingsophør (se pkt.
English: Clinical data in healthy adult subjects indicate that co-administration of a single 100 mg VITRAKVI dose with a single dose of 600 mg rifampin (a P-gp and BCRP inhibitor) increased larotrectinib Cmax and AUC by 1.8-fold and 1.7-fold, respectively.
Danish: Kliniske data fra raske, voksne personer indikerer, at samtidig administration af en enkelt 100 mg VITRAKVI-dosis med en enkeltdosis på 600 mg rifampin (en P-gp og BCRP-inhibitor) forhøjede larotrectinib Cmax og AUC hhv. 1,8 gange og 1,7 gange.
English: Baseline characteristics for the pooled 93 patients with solid tumours with an NTRK gene fusion were as follows: median age 41 years (range 0.1-78 years); 30% < 18 years of age, and 70% ≥ 18 years;
Danish: Baseline-karakteristika for de poolede 93 patienter med solide tumorer med en NTRK-genfusion var følgende: medianalder på 41 år (interval 0,1-78 år), 30 % < 18 år og 70 % ≥ 18 år, 70 % hvide og 53 % mænd; og ECOG PS 0-1 (89 %) eller 2 (11 %).
English: Dizziness Paraesthesia Gait disturbance
Danish: Svimmelhed Paræstesi Gangbesvær
English: The mean volume of distribution of larotrectinib in healthy adult subjects was 48 L following intravenous administration of an IV microtracer in conjunction with a 100 mg oral dose, indicating moderate distribution into tissues from the plasma.
Danish: mikrotracer sammen med en 100 mg oral dosis, hvilket indikerer moderat fordeling i vævet fra plasma.
English: Propylene glycol (E 1520) Potassium sorbate (E 202) Methyl parahydroxybenzoate (E 218) Citrus fruit flavour
Danish: Methylparahydroxybenzoat (E 218) Citrusfrugtsmag
English: NSCLC (n=1)c Soft tissue sarcoma (n=1) Thyroid (n=1)
Danish: Spytkirtel (n = 3) GIST (n = 2)a NSCLC (n = 1)c Bløddelssarkom (n = 1) Thyroidea (n = 1)
English: 50 mg twice daily
Danish: 50 mg 2 gange dagligt
English: Bone sarcoma (n=1) Pancreas (n=1)
Danish: Pankreas (n = 1)
English: Dose and formulation
Danish: Tilbagehold eller seponer
English: Very common Alanine aminotransferase (ALT) increased
Danish: Forhøjet alaninaminotransferase (ALAT)
English: Anaemia Neutrophil count decreased (Neutropenia) Leukocyte count decreased (Leukopenia)
Danish: Anæmi Nedsat neutrofiltal (neutropeni) Nedsat leukocyttal (leukopeni)
English: 50 mg/m2 twice daily
Danish: 50 mg/m2 2 gange dagligt
English: 25 mg/m2 twice daily
Danish: 25 mg/m2 2 gange dagligt
English: What VITRAKVI is and what it is used for What you need to know before you take VITRAKVI How to take VITRAKVI
Danish: Det skal du vide, før du begynder at tage VITRAKVI Sådan skal du tage VITRAKVI Bivirkninger
English: Alanine aminotransferase (ALT) increased Aspartate aminotransferase (AST) increased Weight increased (Abnormal weight gain) Blood alkaline phosphatase increased
Danish: Forhøjet alaninaminotrans ferase (ALAT) Forhøjet aspartataminotran sferase (ASAT) Vægtøgning (unormal vægtstigning) Forhøjet basisk fosfatase i blodet
English: 75 mg/m2 twice daily
Danish: 75 mg/m2 2 gange dagligt
English: Neonate
Danish: Nyfødt
English: If you take more VITRAKVI than you should
Danish: Hvis du har taget for meget VITRAKVI
English: Alanine aminotransferase (ALT) increaseda Aspartate aminotransferase (AST) increased
Danish: Forhøjet alaninaminotrans ferase (ALAT) Forhøjet aspartataminotran sferase (ASAT) Vægtøgning (unormal vægtstigning)
English: Bayer S.p.A. Tel: +39 02 397 8 1
Danish: Tel: +39 02 397 8 1
English: Each mL of oral solution contains larotrectinib sulfate equivalent to 20 mg of larotrectinib.
Danish: Hver ml oral opløsning indeholder larotrectinibsulfat svarende til 20 mg larotrectinib.
English: Dizziness Paraesthesia
Danish: Svimmelhed Paræstesi
English: Each mL of oral solution contains larotrectinib sulfate, equivalent to 20 mg of larotrectinib.
Danish: Hver ml oral opløsning indeholder larotrectinibsulfat, svarende til 20 mg larotrectinib.
English: Natural flavour
Danish: Almindelig Dysgeusi
English: Excretion
Danish: Forstoppelse
English: SD, NE
Danish: SD Ikke relevant
English: Very common Fatigue Common
Danish: Mave-tarm-kanalen Meget almindelig
English: Alanine aminotransferase (ALT) increased Aspartate aminotransferase (AST) increased Weight increased (Abnormal weight gain)
Danish: Forhøjet alaninaminotrans ferase (ALAT) Forhøjet aspartataminotran sferase (ASAT) Vægtøgning (unormal vægtstigning).
English: Appendixa
Danish: Blindtarm
English: PD NA
Danish: PD Ikke relevant
English: Neutrophil count decreased (Neutropenia) Leukocyte count decreased (Leukopenia)
Danish: Nedsatneutrofilta l (neutropeni) Nedsat leukocyttal (leukopeni)
English: Tube diameter for standard feeds
Danish: Sondediameter til standardtilførsler
English: Neutrophil count decreased (Neutropenia)a Leukocyte count decreased (Leukopenia)
Danish: Nedsat neutrofiltal (neutropeni)a Nedsat leukocyttal (leukopeni)
English: b Investigator assessment using either RANO or RECIST v1.1 criteria for primary CNS tumours (9 patients).
Danish: NR: ikke nået; + benævner igangværende a Analyse foretaget af uafhængig bedømmelseskomité (Independent Review Committee) af RESIST v1.1 for solide tumorer bortset fra primære CNS-tumorer (93 patienter) b Vurdering af investigator ved hjælp af enten RANO eller RESIST v1.1 kriterier for primære CNS-tumorer (9 patienter).
English: Hepatic impairment
Danish: Paræstesi Gangbesvær
English: Most of these side effects were also very common in children.
Danish: De fleste af disse bivirkninger var også hyppige hos børn.
English: Atriance received a marketing authorisation valid throughout the EU on 22 August 2007.
Danish: Atriance fik en markedsføringstilladelse med gyldighed i hele EU den 22. august 2007.
English: Atriance has been authorised under ‘exceptional circumstances'.
Danish: Atriance er godkendt under "særlige omstændigheder".
English: This schedule can also be used in patients aged 16 to 21 years.
Danish: Denne doseringsplan kan også anvendes hos patienter i alderen 16 til 21 år.
English: Atriance (nelarabine)
Danish: Atriance (nelarabin)
English: Further information on Atriance can be found on the Agency's website: https://www.ema.europa.eu/en/medicines/human/EPAR/atriance
Danish: Yderligere information om Atriance findes på agenturets websted under: https://www.ema.europa.eu/en/medicines/human/EPAR/atriance
English: The first study involved 70 children and young adults below 21 years of age.
Danish: Det første studie omfattede 70 børn og unge under 21 år.
English: Treatment may be delayed if other side effects occur.
Danish: Behandlingen kan udsættes, hvis der forekommer andre bivirkninger.
English: This means that because the diseases are rare, it has not been possible to obtain complete information about Atriance.
Danish: Det skyldes, at det grundet sygdommens sjældenhed ikke har været muligt at indhente fyldestgørende oplysninger om Atriance.
English: Agency will review any new information that may become available and this overview will be updated as necessary.
Danish: Hvert år gennemgår agenturet alle nye oplysninger, der måtte foreligge, og ajourfører om nødvendigt denne oversigt.
English: The dose and frequency of infusion depend on the patient's age and body surface area (calculated using the patient's height and weight).
Danish: Den anvendte dosis og hyppigheden af infusionerne afhænger af patientens alder og legemsoverflade (beregnet ud fra patientens højde og vægt).
English: As for all medicines, data on the use of Atriance are continuously monitored.
Danish: Som for alle lægemidler bliver data vedrørende brugen af Atriance løbende overvåget.
English: Other information about Atriance
Danish: Andre oplysninger om Atriance
English: Of those whose cancer had not responded (28) five (18%) had a complete response to treatment.
Danish: Blandt de, der ikke havde vist respons (28), viste fem (18 %) fuldstændig respons på behandlingen.
English: Atriance contains the active substance nelarabine.
Danish: Atriance indeholder det aktive stof nelarabin.
English: Patients should be monitored closely for these side effects and treatment stopped if necessary.
Danish: Patienterne bør nøje overvåges for sådanne bivirkninger, og om nødvendigt bør behandlingen bringes til ophør.
English: In both studies, the patients were treated with Atriance, but its effects were not compared with those of any other medicine.
Danish: I begge studier blev patienterne behandlet med Atriance, men dets virkninger blev ikke sammenlignet med virkningerne af andre lægemidler.
English: The European Medicines Agency decided that Atriance's benefits are greater than its risks and it can be authorised for use in the EU.
Danish: Det Europæiske Lægemiddelagentur konkluderede, at fordelene ved Atriance opvejer risiciene, og at det kan godkendes til anvendelse i EU.
English: The most common side effects with Atriance in adults (which may affect more than 1 in 10 people) are infection, febrile neutropenia (low white blood cell counts with fever), neutropenia (low white blood cell counts), thrombocytopenia (low platelet counts), anaemia (low red blood cell counts), somnolence (sleepiness), peripheral neuropathy (damage to the nerves in the extremities), hypoaesthesia (a reduced sense of touch), paraesthesia (unusual sensations like pins and needles), dizziness, headache, dyspnoea (breathlessness), cough, diarrhoea, vomiting, constipation, nausea (feeling sick), myalgia (muscle pain), oedema (swelling), peripheral oedema (swelling in ankles and feet), pyrexia (fever), pain, tiredness and weakness.
Danish: De hyppigste bivirkninger ved Atriance hos voksne (som kan forekomme hos mere end 1 ud af 10 personer) er infektion, febril neutropeni (nedsat antal hvide blodlegemer og feber), neutropeni (nedsat antal hvide blodlegemer), thrombocytopeni (nedsat antal blodplader), anæmi (nedsat antal røde blodlegemer), somnolens (søvnighed), perifer neuropati (beskadigelse af nerverne i ekstremiteterne), hypoæstesi (nedsat følesans), paræstesi (prikkende og stikkende fornemmelse), svimmelhed, hovedpine, dyspnø (stakåndethed), hoste, diarré, opkastning, forstoppelse, kvalme, myalgi (muskelsmerter), ødemer (hævelse), perifere ødemer (hævelse af ankler og fødder), pyreksi (feber), smerter, træthed og kraftesløshed.
English: Treatment should be stopped if the patient develops serious side effects affecting the brain or nervous system.
Danish: Behandlingen bør bringes til ophør, hvis der opstår alvorlige bivirkninger, som påvirker hjernen eller nervesystemet.
English: Since Atriance has been authorised under exceptional circumstances, the company that markets Atriance will provide yearly updates from a study on the effectiveness and safety of Atriance in children and young adults.
Danish: Eftersom Atriance er godkendt under særlige omstændigheder, vil virksomheden, der markedsfører Atriance, fremlægge årlige opdateringer fra et studie af Atriances effektivitet og sikkerhed hos børn og unge voksne.
English: What measures are being taken to ensure the safe and effective use of Atriance?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Atriance?
English: An overview of Atriance and why it is authorised in the EU
Danish: En oversigt over Atriance, og hvorfor det er godkendt i EU
English: In the second study, involving a total of 40 adults and adolescents above the age of 16.
Danish: Det andet studie omfattede i alt 40 voksne og unge over 16 år.
English: The Agency noted that, due to the small number of patients with these diseases, the information to support the authorisation of Atriance is limited, but it agreed that the medicine could allow some patients to go on to receive bone-marrow transplantation, increasing their chances of survival.
Danish: Agenturet konstaterede, at der som følge af det beskedne antal patienter med disse sygdomme kun foreligger begrænsede oplysninger til støtte for godkendelsen af Atriance, men fandt, at lægemidlet kan give nogle patienter mulighed for at gå videre til knoglemarvstransplantation, hvorved deres overlevelsesmuligheder øges.
English: This stops the production of DNA and thus slows down the growth and multiplication of cells.
Danish: Dette forhindrer dannelsen af dna og forhaler således cellernes vækst og formering.
English: Why is Atriance authorised in the EU?
Danish: Hvorfor er Atriance godkendt i EU?
English: Side effects reported with Atriance are carefully evaluated and any necessary action taken to protect patients.
Danish: De indberettede bivirkninger ved Atriance vurderes omhyggeligt, og der træffes de nødvendige forholdsregler for at beskytte patienterne.
English: Atriance was shown to be effective in two main studies involving patients with T-ALL and T-LBL whose cancer had stopped responding to one or more previous cancer treatments.
Danish: Atriance viste sig at være effektivt i to hovedstudier, der omfattede T-ALL- og T-LBL-patienter, hos hvem en eller flere tidligere kræftbehandlinger var holdt op med at virke.
English: What is Atriance and what is it used for?
Danish: Hvad er Atriance, og hvad anvendes det til?
English: Patients aged under 16 years receive a dose of 650 mg per square metre given over one hour on five consecutive days, repeated every 21 days.
Danish: Patienter under 16 år får en mindre dosis på 650 mg pr. kvadratmeter, givet i løbet af én time i fem på hinanden følgende dage og gentaget hver 21. dag.
English: For more information about using Atriance, see the package leaflet or contact your doctor or pharmacist.
Danish: Hvis du ønsker mere information om anvendelsen af Atriance, kan du læse indlægssedlen eller kontakte lægen eller apotekspersonalet.
English: Atriance can only be obtained with a prescription and is given by drip into a vein under the supervision of a doctor who has experience in the use of thes type of medicine.
Danish: Atriance fås kun på recept og gives ved drop i en vene under opsyn af en læge med erfaring i anvendelse af denne type lægemidler.
English: Severe side effects affecting the brain and nervous system have also been reported in patients taking Atriance, including somnolence, convulsions, and peripheral neuropathy causing numbness, unusual sensations, weakness and even paralysis.
Danish: Der er også indberettet svære bivirkninger i hjernen eller nervesystemet hos patienter, som tager Atriance, herunder somnolens, krampeanfald og perifer neuropati, som giver følelsesløshed, usædvanlige sanseindtryk, kraftesløshed og tilmed lammelse.
English: The active substance in Atriance, nelarabine, is a cytotoxic, a medicine that kills cells that are dividing, such as cancer cells.
Danish: Det aktive stof i Atriance, nelarabin, er et cytotoksisk stof, dvs. et lægemiddel, der dræber celler, der deler sig, f.eks. kræftceller.
English: In adults and adolescents aged 16 years and over, the recommended starting dose is 1,500 mg per square metre of body surface area, given over two hours on days one, three and five, repeated every 21 days.
Danish: Hos voksne og hos unge i alderen 16 år og derover er den anbefalede startdosis 1.500 mg pr. kvadratmeter legemsoverflade, givet i løbet af to timer på dag 1, 3 og 5 og gentaget hver 21. dag.
English: Of those whose cancer had not responded to two or more previous treatments (39) five (13%) had a complete response to treatment after a month, with no evidence of disease and normal blood counts.
Danish: Blandt de, der ikke viste respons på to eller flere tidligere behandlinger (39), viste fem (13 %) fuldstændig respons på behandlingen efter en måned, dvs. de var fri for sygdomstegn og havde normale blodtal.
English: Atriance is a cancer medicine used to treat patients with T-cell acute lymphoblastic leukaemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LBL).
Danish: Atriance er et kræftlægemiddel, der anvendes til behandling af patienter med akut lymfoblastisk Tcelle-leukæmi (T-ALL) eller lymfoblastisk T-celle-lymfom (T-LBL).
English: What information is still awaited for Atriance?
Danish: Hvilke oplysninger afventes der stadig for Atriance?
English: In the body, this analogue takes the place of guanine and interferes with the enzymes involved in making new DNA, DNA polymerases.
Danish: I kroppen går denne analog ind på guaninets plads og forstyrrer virkningen af de enzymer, der medvirker ved dannelsen af nyt dna, dna-polymeraser.
English: Because the guanine analogue accumulates in Tcells and lasts longer in these cells, Atriance slows down the growth and multiplication of the cells involved in T-ALL and T-LBL.
Danish: Da den aktive guaninanalog ophobes i T-cellerne og forbliver længere i disse celler, bremser Atriance væksten og formeringen af de celler, der optræder ved T-ALL og T-LBL.
English: What are the risks associated with Atriance?
Danish: Hvilke risici er der forbundet med Atriance?
English: For the full list of side effects and restrictions of Atriance, see the package leaflet.
Danish: Den fuldstændige liste over bivirkninger og begrænsninger ved Atriance fremgår af indlægssedlen.
English: Nelarabine is converted within cells into an analogue of guanine, one of the fundamental chemicals that make up DNA.
Danish: I cellerne omdannes nelarabin til en guanin-analog, dvs. et stof, der ligner guanin, som er en af de grundlæggende kemiske byggesten i dna.
English: In both studies, compared to patients who had a complete response more patients had a partial response to Atriance treatment, with blood counts returning towards normal levels.
Danish: I begge studier viste en større del af patienterne delvis respons på behandlingen med Atriance, med blodtal, der vendte tilbage til normalområdet, sammenlignet med patienter, der viste fuldstændig respons.
English: Atriance is used when the cancer has not responded to, or has stopped responding to, at least two types of chemotherapy.
Danish: Atriance anvendes, når mindst to typer kemoterapi har været uden virkning eller ikke længere virker.
English: How is Atriance used?
Danish: Hvordan anvendes Atriance?
English: These are types of cancer where T-lymphoblasts (a type of immature white blood cell) multiply too quickly.
Danish: Disse kræftformer skyldes uhæmmet vækst af T-lymfoblaster (en art umodne hvide blodlegemer).